SCHEMBL22249679

SCHEMBL22249679

c1ccc2c(c1)c1ccccc1c1cc3c(cc21)oc1cncnc13

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 2/20 0.36
LIMK1 P53667 1/20 0.35
ALDH1A1 P00352 7/20 0.33
HPGD P15428 5/20 0.33
MAPT P10636 3/20 0.33
AHR P35869 2/20 0.33
LMNA P02545 4/20 0.32
NPC1 O15118 2/20 0.32
RAB9A P51151 2/20 0.32
KMT2A Q03164 3/20 0.32
GPR55 Q9Y2T6 1/20 0.32
KDM4E B2RXH2 2/20 0.32
MEN1 O00255 2/20 0.32
EGFR P00533 1/20 0.32
CYP1A2 P05177 1/20 0.31
CYP2C9 P11712 1/20 0.31
CYP2C19 P33261 1/20 0.31
TSHR P16473 1/20 0.31
CASP3 P42574 1/20 0.31
HSD17B10 Q99714 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22483138 0.83 EGFR (0.39) SMN1; SMN2LIMK1ALDH1A1HPGDLMNA
SCHEMBL483929 0.82 SMN1; SMN2 (0.51) SMN1; SMN2LIMK1ALDH1A1HPGDMAPT
SCHEMBL22249796 0.77 KDM4E (0.36) SMN1; SMN2ALDH1A1HPGDMAPTAHR
SCHEMBL31485757 0.76 PLA2G2A (0.42) SMN1; SMN2LIMK1LMNACYP1A2
SCHEMBL18381852 0.76 KDM4E (0.36) SMN1; SMN2LIMK1ALDH1A1HPGDMAPT
SCHEMBL22249944 0.76 MEN1 (0.42) SMN1; SMN2ALDH1A1HPGDMAPTAHR
SCHEMBL26423435 0.75
SCHEMBL22249688 0.74 AHR (0.38) SMN1; SMN2ALDH1A1HPGDMAPTAHR
SCHEMBL26423361 0.74 PDGFRB (0.40) SMN1; SMN2ALDH1A1MAPTLMNANPC1
SCHEMBL16982232 0.74 SMN1; SMN2 (0.35) SMN1; SMN2LIMK1ALDH1A1HPGDMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200235306-A1 ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME LUMINESCENCE TECHNOLOGY CORPORATION (TW) 2020-07-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200235306-A1 ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME OR10J3, PIEZO1, ODC1 SMN1; SMN2 1178/4885LIMK1 337/4885ALDH1A1 63/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.